1Fioretto P, Bruseghin M, Barzon I, et al. Diabetic nephropathy: An update on renal structure[J]. International Congress Series, 2007, 1303: 51-59.
2Lai FMM, Szeto CC, Choi PCL, et al. Isolate diffuse thickening of glomerular capillary basement membrane: a renal lesion in prediabetes?[J]. Modem Pathology, 2004, 17: 1506-1512.
3Fioretto P, Steffes MW, Mauer M. Glomerular structure in non- proteinuric insulin-dependent diabetic patients with various levels of albuminuria[J]. Diabetes, 1994, 43: 1358-1364.
4Lerco MM, Macedo CS, Silva RJ, et al. The of podocyte and slit diaphragm is decreased in experimental diabetic nephropathy[J]. Acta Cjr Bras, 2006, 21(2): 87-9l.
5White KE, Bilous Rw, Marshall SM, et al. Podocyte number in normotensive type 1 diabetic patients with albuminuria[J]. Diabetes, 2002, 51(10): 3083-3089.
6Morrisey K, Steadman R, Williams JD, et al. Renal proximal tubular cell fibroneetin accumulation in response to glucose is polyol pathway dependent[J]. Kidney lnt, 1999, 55( 1 ): 160-167.
8Ziyadeh FN. Renal tubular basement membrane and collagen type IV in diabetes mellitus[J]. Kidney International ,1993, 43: 114-120.
9Nengaard JR, Nyengaard JR, Flyvbjerg A, et al. The impact of renal growth, regression and regrowth in experimental diabetes mellitus on number and size of proximal and distal tubular cells in the rat kidney[J]. Diabetologia, 1993, 36(11): 1126-1131.
4Moliteh ME, DeFronzo RA, Franz M J, et al. Diabetic nephropathy[ J ]. Diabetes Care, 2003, 26 ( Supple 1 ) : S94 - S98.
5Wilkinson - Berka JL, Kelly DJ, Koerner SM, et al.ALT - 946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic ( mREN - 2) 27 rat [ J ]. Diabetes, 2002, 51 ( 11 ) :3283 - 3289.
6Soler M J, Wysocki J, Ye M, et al. ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin- induced diabetic mice [J]. Kidney Int, 2007, 72(5) :614 -623.
7Wolf G. Cell cycle regulation in diabetic nephropathy [ J ]. Kidney Int Suppl, 2000, 77 :$59 - $66.
8Davis B J, Cao Z, de Gasparo M, et al. Disparate effects of angiotensin Ⅱ antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrin [ J ]. J Hypertens, 2003, 21 ( 1 ) :209 - 216.
9Vieitez P, Gomez O, Uceda ER, et al. Systemic and local effects of angiotensin II blockade in experimental diabetic nephropathy [ J ]. J Renin Angiotensin Aldosterone Syst, 2008, 9(2) :96 - 102.
10Thomas MC, Forbes JM, Cooper ME. Advanced glycation end products and diabetic nephropathy[ J ]. Am J Ther, 2005, 12(6) :562 -572.
